Medications for Eosinophilic Granulomatosis With Polyangiitis

2 results

  • fasenra - benralizumab injection, solution

    (Benralizumab)
    Astrazeneca Pharmaceuticals Lp
    Fasenra is used as add-on maintenance treatment for severe eosinophilic asthma in adults and children aged 6 and older, and for treating eosinophilic granulomatosis with polyangiitis (EGPA) in adults.
    Medication Details
    Drug Interactions

  • nucala - mepolizumab injection, powder, for solution

    (Mepolizumab)
    Glaxosmithkline Llc
    Nucala treats severe eosinophilic asthma (age 6+), chronic rhinosinusitis with nasal polyps (adults), eosinophilic COPD (adults), eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (age 12+). Not for acute bronchospasm.
    Medication Details
    Drug Interactions